EGFR and neoplasm: Besides, all the patients with LncRNA H19 SNP rs2107425 T allele (CT + TT) experienced a severe tumor T status (stage III or IV, p = 0.025), while the phenomenon was more prominent in patients with both EGFR wild-type and LncRNA H19 SNP rs2107425 CT + TT (stage III or IV, p = 0.007) compared to EGFR wild-type LADC individuals with LncRNA H19 SNP rs2107425 CC allele.